miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review: Molecular Therapy - Nucleic Acids
Comprehensive molecular characterization of clear cell renal cell carcinoma | Nature
Frontiers | The Identification of Immunological Biomarkers in Kidney Cancers
Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research | British Journal of Cancer
Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach - eBioMedicine
An Immune Atlas of Clear Cell Renal Cell Carcinoma - ScienceDirect
Kidney Cancer: Recent Advances and Future Directions | Journal of Clinical Oncology
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population | Nature Communications
Frontiers | Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer
Renal cancer biomarkers: the promise of personalized care | BMC Medicine | Full Text
Biomarkers in renal cell carcinoma: Towards a more selective immune checkpoint inhibition - ScienceDirect
Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature - ScienceDirect
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
Synthetic biomarkers: a twenty-first century path to early cancer detection | Nature Reviews Cancer
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
Self-Referenced Synthetic Urinary Biomarker for Quantitative Monitoring of Cancer Development | Journal of the American Chemical Society
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma - ScienceDirect
Biomarkers in drug discovery and development
Mapping the immune environment in clear cell renal carcinoma by single-cell genomics | Communications Biology
How are biomarkers used to treat cancer? | MD Anderson Cancer Center
Frontiers | IFI16 Can Be Used as a Biomarker for Diagnosis of Renal Cell Carcinoma and Prediction of Patient Survival
Determinants of renal cell carcinoma invasion and metastatic competence | Nature Communications
Biomarkers in renal cell carcinoma: Are we there yet? - ScienceDirect
